Hepatitis C Infection and Related Factors in Hemodialysis Patients in China: Systematic Review and Meta-Analysis

Sun, Jinghua; Yu, Rongbin; Zhu, Bei; Wu, Jianqing; Larsen, Steven H.; Zhao, Weihong

doi:10.1080/08860220903003446

Cited by 50 publications

(51 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…our result was greater than that found among haemodialysis patients in Sudan (6.5%, 8.5% and 23.7%) [28,31,29]. Also our findings greater than that in developed countries, in USA 14%, in France (15%), United Kingdom (4%), Germany (7%) and Spain (22%) [16,17,26]. Our finding was lower than that found haemodialysis patients; in Egypt (52.3 to 82.3%), in Saudi Arabia (52.5%), in Yemen (33.8%), in Syria (24.4 to 48.9%), in Kosova 43% and in China (41.1%) [9, 24 , 25,26,27].…”

Section: Discussioncontrasting

confidence: 52%

See 1 more Smart Citation

Prevalence and Risk Factors of HCV Infection among Haemodialysis Patients at Dialysis Centers in Khartoum State - Sudan

Abdalla¹,

Shaaban²,

Elkhidir³

2017

IOSR JDMS

View full text Add to dashboard Cite

Hepatitis C virus share razors. P values = (0.0001, 0.0031, 0.0001, 0.0018, 0.0005 and 0.0002) Results: Field workers interviewed ten dialysis centers with a total of 287 study subjects. Sixty out of 287 (20.9%) was found to be anti-HC reactive. The multivariate analysis indicated as risk factors associated to anti-HCV positivity the number of blood transfusion received, duration of dialysis treatment, number of units of treatment, history of surgeries, multiple injections and using

show abstract

Section: Discussioncontrasting

confidence: 52%

“…The prevalence rates in developed countries such as in Japan (2.5%), Holland (4%), the United Kingdom (4%), Germany (7%), Belgium (7%) and Sweden (10%) are low. However, prevalence is a little bit higher in the USA (14%), France (15%), Spain (22%) and Italy (30%), in China 41.1% [16,17,26].…”

Section: Introductionmentioning

confidence: 99%

Prevalence and Risk Factors of HCV Infection among Haemodialysis Patients at Dialysis Centers in Khartoum State - Sudan

Abdalla¹,

Shaaban²,

Elkhidir³

2017

IOSR JDMS

View full text Add to dashboard Cite

show abstract

“…Patients undergoing hemodialysis (HD) are at a higher risk of HCV exposure due to sharing of dialysis machines [8]. It has been estimated that HD increases the odds of acquiring HCV by five folds [9]. Characterizing HCV infection levels in HD patients and controlling its transmission through this mode of exposure are integral to improving the quality and healthcare utilization of HD.…”

Section: Introductionmentioning

confidence: 99%

Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions

et al. 2017

View full text Add to dashboard Cite

SUMMARYWe aimed to investigate hepatitis C virus (HCV) epidemiology among hemodialysis (HD) patients in the Middle East and North Africa (MENA). Our data source was an HCV biological measures database populated through systematic literature searches. Descriptive epidemiologic syntheses, effects meta-analyses and meta-regressions, and genotype analyses were conducted. We analyzed 289 studies, including 106 463 HD patients. HCV incidence ranged between 0 and 100% as seroconversion risk, and between 0 and 14·7 per 1000 person-years as incidence rate. The regional pooled mean estimate was 29·2% (95% CI: 25·6-32·8%) for HCV antibody positive prevalence and 63·0% (95% CI: 55·4-70·3%) for the viremic rate. Region within MENA, country income group, and year of data collection were associated with HCV prevalence; year of data collection adjusted odds ratio was 0·92 (95% CI: 0·90-0·95). Genotype diversity varied across countries with four genotypes documented regionally: genotype 1 (39·3%), genotype 2 (5·7%), genotype 3 (29·6%), and genotype 4 (25·4%). Our findings showed that one-third of HD patients are HCV antibody positive and one-fifth are chronic carriers and can transmit the infection. However, HCV prevalence is declining. In context of growing HD patient population and increasing HCV treatment availability, it is critical to improve standards of infection control in dialysis and expand treatment coverage.

show abstract

“…The prevalence of HCV infection among HD patients varies widely, ranging from 5% to approximately 40%, depending on the geographic region. Thus, these patients still represent a high risk group for the acquisition of HCV infection [5][6][7]. Prevalence of anti-HCV positive patients among those on HD in Serbia was found to be high, but showing tendency to decrease (31-23%) [8].…”

Section: Discussionmentioning

confidence: 99%

Successful treatment of chronic hepatitis C in a hemodialysis

Milošević

Karić

Pešić-Pavlović

et al. 2018

J Infect Dev Ctries

View full text Add to dashboard Cite

show abstract

Hepatitis C Infection and Related Factors in Hemodialysis Patients in China: Systematic Review and Meta-Analysis

Abstract: Viral hepatitis is still one of the main complications in HD patients, with hepatitis C being the most common one. The key to reducing the incidence of viral hepatitis in HD patients is to control contagion and reduce the frequency of blood transfusion and cross-infection.

Cited by 50 publications

References 19 publications

Prevalence and Risk Factors of HCV Infection among Haemodialysis Patients at Dialysis Centers in Khartoum State - Sudan

Prevalence and Risk Factors of HCV Infection among Haemodialysis Patients at Dialysis Centers in Khartoum State - Sudan

Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions

Successful treatment of chronic hepatitis C in a hemodialysis

Contact Info

Product

Resources

About